Figure 6.

The cumulative overall survival (OS) of patients with high soluble N-cadherin (sN-CAD) levels, compared to patients with low sN-CAD levels.

Niimi et al. BMC Cancer 2013 13:309   doi:10.1186/1471-2407-13-309
Download authors' original image